Hepatitis B in chronic kidney disease: Moving toward effective prevention

Kidney International

Volumn 73, Issue 7, 2008, Pages 799-801

  Unger, J K ^a   Peters, H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT;

ANTIBODY RESPONSE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; KIDNEY FAILURE; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 40849113105     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.57     Document Type: Note

References (10)

1. Shepard CW, Simard EP, Finelli L et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125.
2. Lai LL, Ratzui V, Yuen MF, Pynard T. Viral hepatitis B. Lancet 2003; 362: 2089-2094.
3. Pollard AJ. Hepatitis B vaccination. BMJ 2007; 335: 950.
4. Fabrizi F, Bunnapradist S, Martin P. HBV infection in patients with end-stage renal disease. Semin Liver Dis 2004; 24(Suppl 1): 63-70.
5. Tang S, Lai KN. Chronic viral hepatitis in hemodialysis patients. Hemodial Int 2005; 9: 169-179.
6. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001; 50(RR-5): 1-43.
7. Fehr T, Ambühl PM. Chronic hepatitis virus infections in patients on renal replacement therapy. Nephrol Dial Transplant 2004; 19: 1049-1053.
8. Kong NCT, Beran J, Kee SA et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 2008; 73: 856-862.
9. Pulendran B. Tolls and beyond: many roads to vaccine immunity. N Engl J Med 2007; 356: 1776-1778.
10. Krieg AM. Toll-free vaccines? Nat Biotechnol 2007; 25: 303-305.